K. Tsuji et al., STUDIES ON ANTIINFLAMMATORY AGENTS .4. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF 1,5-DIARYLPYRAZOLES AND RELATED DERIVATIVES, Chemical and Pharmaceutical Bulletin, 45(6), 1997, pp. 987-995
A series of novel 1,5-diarylpyrazole derivatives was synthesized and t
ested for anti-inflammatory and analgesic activities to develop anti-i
nflammatory agents with fewer side effects than existing nonsteroidal
anti-inflammatory drugs, The structure-activity relationships in this
series were extensively studied. Electron-withdrawing substituents suc
h as CN and CF3 were optimal at the 3-position of the pyrazole ring, R
eplacement of these substituents with bulky ones gave less active comp
ounds. The 4-(methylsulfonyl)phenyl group seemed to be the optimal gro
up at the 5-position of the pyrazole ring. The most potent compound wa
s 1-(4-fluorophenyl)-5-[4-(methylsulfonyl)phenyl]- pyrazole-3-carbonit
rile (19a), with oral ED50 values of 0.030 and 0.47 mg/kg on adjuvant-
induced arthritis and collagen-induced arthritis, respectively, and an
ED30 value of 7.4 mg/kg in the yeast-induced hyperalgesia (Randall-Se
litto) assay. Compound 19a also showed potent inducible cyclooxygenase
(COX-2)-inhibitory activity (IC50 = 0.24 mu m) with no COX-1 inhibiti
on even at 100 mu m.